Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
13.23
-0.34 (-2.51%)
At close: Dec 5, 2025, 4:00 PM EST
13.24
+0.01 (0.08%)
After-hours: Dec 5, 2025, 5:01 PM EST
IART Revenue
Integra LifeSciences Holdings had revenue of $402.06M in the quarter ending September 30, 2025, with 5.57% growth. This brings the company's revenue in the last twelve months to $1.64B, up 4.99% year-over-year. In the year 2024, Integra LifeSciences Holdings had annual revenue of $1.61B with 4.47% growth.
Revenue (ttm)
$1.64B
Revenue Growth
+4.99%
P/S Ratio
0.62
Revenue / Employee
$373,741
Employees
4,396
Market Cap
1.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.61B | 68.95M | 4.47% |
| Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
| Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
| Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
| Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
| Dec 31, 2019 | 1.52B | 45.12M | 3.06% |
| Dec 31, 2018 | 1.47B | 284.21M | 23.92% |
| Dec 31, 2017 | 1.19B | 196.16M | 19.77% |
| Dec 31, 2016 | 992.08M | 109.34M | 12.39% |
| Dec 31, 2015 | 882.73M | 86.02M | 10.80% |
| Dec 31, 2014 | 796.72M | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | 830.87M | 50.79M | 6.51% |
| Dec 31, 2011 | 780.08M | 48.01M | 6.56% |
| Dec 31, 2010 | 732.07M | 49.58M | 7.26% |
| Dec 31, 2009 | 682.49M | 27.88M | 4.26% |
| Dec 31, 2008 | 654.60M | 104.15M | 18.92% |
| Dec 31, 2007 | 550.46M | 131.16M | 31.28% |
| Dec 31, 2006 | 419.30M | 141.36M | 50.86% |
| Dec 31, 2005 | 277.94M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IART News
- 2 days ago - Integra LifeSciences Holdings Corporation (IART) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 days ago - Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - GlobeNewsWire
- 10 days ago - Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - GlobeNewsWire
- 24 days ago - Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries - GlobeNewsWire
- 5 weeks ago - Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Integra LifeSciences Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 - GlobeNewsWire
- 2 months ago - Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting - GlobeNewsWire